INSIGHTS ON CLINICAL TRIAL DESIGN
-
Precision Medicine: Targeted Cancer Therapies
Cancer research is entering a new precision-driven era, with targeted therapies focusing on the specific genetic or molecular mechanisms that fuel tumor growth.
-
Managing Drug And Data Requirements In Decentralized Clinical Trials
Running a global decentralized clinical trial requires a deep understanding of the differences in FDA and EMA requirements for investigational products and patient data.
-
A Practical Guide To Harnessing The Value Of APAC For Global Trial Success
As Phase III costs and complexity rise, APAC offers faster enrollment, lower costs, and market access advantages, but capturing that value requires early planning and in-region expertise.
-
IRT: A New Approach To Meeting The Needs Of Early Phase Trials
As early phase clinical trials become more sophisticated, sponsors are now leveraging flexible IRT solutions to replace error-prone manual processes and gain greater control and efficiency.
-
Streamlining Phase 1 Trials With The Mobile Vision Pod1/29/2025
A contract research organization formed a partnership to address significant challenges during a Phase 1 clinical trial for a corneal disease treatment through the use of a Mobile Vision Pod.
-
Breaking Through Barriers With Integrated Trial Optimization5/9/2025
In today’s complex clinical trial environment, optimizing trial design requires a multidimensional strategy that balances scientific rigor with real-world constraints.
-
How Community-Based Research Models Expand Access9/9/2025
As momentum continues to grow in neurology research, how can community-based research models help overcome recruitment and retention challenges in complex areas like Alzheimer's?
-
Turning Rapid Study Start-Up Into Enrollment Momentum9/18/2026
A large Phase III ATTR-CM outcomes trial spanning 37 countries reached 50% enrollment eight months early, with monthly accrual rates running 3–5x above plan through coordinated cross-functional execution.
-
Improving Clinical Research Efficiency And Access For Underserved Populations3/26/2026
Modernizing data workflows removes geographic barriers to clinical trials, ensuring rural patients access innovative care while reducing administrative burdens on dedicated research staff.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Our network of 150+ active clinical trial sites allows us to identify potential partners that align with your therapeutic area, geographic preference, and specialty population requirements.
-
A successful clinical trial starts with an efficient protocol review.
With deep roots in academic research and clinical medicine, BRANY IRB is uniquely positioned to meet your cost and speed requirements. Get your clinical trial to the start line while ensuring participant health and safety.
-
CSSi offers unmatched depth and breadth in therapeutic expertise, providing full-spectrum, in-house capabilities, positing the organization as a true end-to-end partner in clinical trials.
-
By conducting trial visits outside of the site, physicians can expand their reach, making drug development more accessible. Read about how MRN's Home Trial Support "HTS" is the engine powering DCTs.
-
Through Home Trial Support (HTS), it is possible to carry out even the most demanding sampling protocols safely, consistently, and at scale—bringing collection and processing directly to patients.